ATLAS / Macro Radar / Reporting / ARTV

Artiva Biotherapeutics, Inc. (ARTV) reporting calendar

Artiva Biotherapeutics, Inc. files periodic reports with the SEC as ARTV on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
8 May 2026
Reports on record
8

How this window is derived. Derived from this issuer's own filing history: 8 periods at a median 92-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ARTV market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20268 May 202638 days0001193125-26-213242
10-K31 Dec 202510 Mar 202669 days0001193125-26-100135
10-Q30 Sep 202512 Nov 202543 days0001193125-25-275872
10-Q30 Jun 20256 Aug 202537 days0000950170-25-104045
10-Q31 Mar 20258 May 202538 days0000950170-25-066421
10-K31 Dec 202424 Mar 202583 days0000950170-25-043837
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125382
10-Q30 Jun 202429 Aug 202460 days0001193125-24-209924

Source: SEC EDGAR company submissions for CIK 0001817241. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.